MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Bias in Pharmacoepidemiological Studies of Parkinson’s Disease Prescribing Patterns: A Systematic Review

K. Orayj (Abha, Saudi Arabia)

Meeting: 2025 International Congress

Keywords: Parkinson’s, Pharmacotherapy

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: This systematic review aims to identify and evaluate reported biases in pharmacoepidemiological studies on nonrandomized prescribing patterns, drug utilization, or treatment trends in PD.

Background: Pharmacoepidemiological studies are crucial for understanding prescribing trends and treatment outcomes in Parkinson’s disease (PD). However, biases within these studies can undermine the reliability of evidence and impact clinical decision-making.

Method: A systematic search was conducted in PubMed, Embase, and Web of Science for pharmacoepidemiological studies published from the outset until November 30, 2024. The search focused on studies investigating nonrandomized prescribing patterns, drug utilization, or treatment trends in PD. Inclusion criteria required studies that explicitly reported or demonstrated biases. Types of bias analyzed included confounding, selection bias, and information bias.

Results: Of 63 studies identified, 17 met the inclusion criteria. Common biases included confounding due to disease severity or comorbidities (present in 58.8% of studies) and selection bias from non-representative patient populations (41.1%). Recall bias, as a form of information bias, was reported in 17.6% of studies. Geographic disparities in prescribing practices were also observed, potentially reflecting systemic biases. Few studies (23.5%) adequately addressed methodological limitations, such as appropriate adjustment for confounders or stratification by disease progression. Only one study (5.8%) used the ROBINS-I tool to assess and report biases.

Conclusion: Although 63 studies were identified, only about 27% explicitly reported some form of methodological bias. Considering that these types of studies are inherently prone to biases, this suggests a lack of awareness among researchers regarding the identification and reporting of biases in pharmacoepidemiological studies on PD. Improved study designs and heightened researcher awareness are necessary to enhance the validity and reliability of evidence in this field.

To cite this abstract in AMA style:

K. Orayj. Bias in Pharmacoepidemiological Studies of Parkinson’s Disease Prescribing Patterns: A Systematic Review [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/bias-in-pharmacoepidemiological-studies-of-parkinsons-disease-prescribing-patterns-a-systematic-review/. Accessed November 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/bias-in-pharmacoepidemiological-studies-of-parkinsons-disease-prescribing-patterns-a-systematic-review/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley